Digital Therapeutic Self-Management Intervention in Adolescents With Inflammatory Bowel Disease.
Digital Therapeutic Self-Management Intervention in Adolescents With Inflammatory Bowel Disease.
复制标题
患有炎症性肠病的青少年的数字治疗自我管理干预。
DOI：
10.1097/mpg.0000000000003623
复制
发表时间：
2023
影响因子：
2.9
通讯作者：
Denson,LeeA
中科院分区：
文献类型：
--
作者：
Hommel,KevinA;Ramsey,RachelleR;Gray,WendyN;Denson,LeeA
本研究的目的是设计，编码和测试儿科炎症性肠病（IBD）数字治疗自我管理工具的可行性，可接受性和初步疗效。推荐治疗的自我管理援助门户网站的开发涉及一个迭代的共同设计过程，其中包括与关键利益攸关方举行的一系列焦点小组/访谈会议。随后，对22例患者进行了一项试点、单臂、开放标签试验;药物依从性是主要结局。SMART门户网站的使用数据良好，患者表现出比父母更好的参与。试验结果表明，药物依从性（M= 24%-31%; t= 7.94，P< 0.05）和自我管理障碍以及健康相关生活质量和症状的趋势有所改善。SMART门户网站是一种可行的儿科IBD数字治疗自我管理工具，在这项试点试验中证明了初步疗效。需要大型对照试验来明确确定该工具的临床疗效。
The objective of this study was to design, code, and test the feasibility, acceptability, and preliminary efficacy of a digital therapeutic self-management tool for pediatric inflammatory bowel disease (IBD). The Self-Management Assistance for Recommended Treatment (SMART) portal development involved an iterative co-design process with a series of focus group/interview sessions with key stakeholders. Subsequently, a pilot, single-arm, open-label trial was conducted with 22 patients; medication adherence was the primary outcome. Usage data for the SMART portal were good, with patients demonstrating better engagement than parents. Results from the trial demonstrated improvement in medication adherence (M= 24%–31%; t= 7.94, P< 0.05) and self-management barriers as well as trends in health-related quality of life and symptoms. The SMART portal is a feasible digital therapeutic self-management tool for pediatric IBD that demonstrated preliminary efficacy in this pilot trial. Large, controlled trials are needed to definitively determine the clinical efficacy of this tool.